Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)
20 March 2020 - 9:01PM
Edgar (US Regulatory)
Filed
by OpGen, Inc.
Pursuant
to Rule 425 under the
Securities
Act of 1933, as amended
and
deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934
Subject
Company: OpGen, Inc.
Commission
File No: 001-37367
Date:
March 19, 2020
|
200
Broadacres Drive, 3rd Floor
Bloomfield, NJ 07003
P: 973.873.7700
F: 973.338.1430
www.allianceadvisors.com
|
Date
Urgent
Reminder
Dear
OpGen Inc. Stockholder:
Our
records indicate your vote has not yet been received for the 2020 Special Meeting of Stockholders which has been adjourned until
March 30, 2020.
We
are pleased that the leading independent proxy advisory firm, Institutional Shareholder Services, Inc. (ISS) recommended that
holders vote with the board’s recommendation, in favor of all proposals.
Stockholders
are reminded that their vote is extremely important, no matter how many or how few shares they own.
The
fastest and easiest way to vote is to call 800-574-6217 and speak with one of our proxy
specialists between the hours of 9:00 a.m. and 10:00 p.m., Eastern Time, Monday through Friday and 10:00 a.m. and 6:00 p.m. Eastern
Time, Saturday and Sunday.
Thank
you in advance for your support.
Sincerely,
/s/
Melissa Calson
Melissa Carlson
Vice
President
Additional
Information and Where to Find It
In
connection with the transactions contemplated by the Implementation Agreement (the definitive agreement related to the proposed
business combination between the Company and Curetis GmbH), a Registration Statement on Form S-4 (File No. 333-234657) has been
filed with and declared effective by the Securities and Exchange Commission (the “SEC”). Investors and security holders
are encouraged to read the registration statement and any other relevant documents filed with the SEC, including the proxy statement
that forms a part of the registration statement. Such documents contain important information about the proposed transaction.
The definitive proxy statement was first mailed to stockholders of the Company on or about January 27, 2020. This communication
is not a substitute for the registration statement, the proxy statement or any other document that OpGen may send to its stockholders
in connection with the proposed transaction. Investors and security holders will be able to obtain the documents free of charge
at the SEC’s website, www.sec.gov, or from the Company at its website, www.opgen.com.
OpGen (NASDAQ:OPGN)
Historical Stock Chart
From Aug 2024 to Sep 2024
OpGen (NASDAQ:OPGN)
Historical Stock Chart
From Sep 2023 to Sep 2024